Back
Matinas BioPharma Holdings Stock Predictions
Sponsored
MTNB
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.71
Seasonality Move:
10.35%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereMatinas BioPharma Holdings Stock Forecast
-
Is Matinas BioPharma Holdings Stock Undervalued?
The current Matinas BioPharma Holdings [MTNB] share price is $0.75. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Matinas BioPharma Holdings Stock Go Up Next Year?
Data Unavailable
Matinas BioPharma Holdings Stock Rating
Data Unavailable
Matinas BioPharma Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
matinasbiopharma.com
52-Week Data
52-Week High:
21.50
52-Week Low:
0.50
Prediction Charts
Market Cap:
3.74M
Price in USD:
0.75
Volume:
442.17K
Beta:
1.74
Technical Analysis
SMA50:
2.94
SMA100:
1.54
SMA200:
0.88
52-Wk Change:
-93%
Stock Predictions
-
Is Matinas BioPharma Holdings stock public?
Yes, Matinas BioPharma Holdings is a publicly traded company. -
What is the Matinas BioPharma Holdings stock quote today?
The Matinas BioPharma Holdings stock price is 0.75 USD today. -
How to buy Matinas BioPharma Holdings stock online?
You can buy Matinas BioPharma Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-24 | 3.31 | 3.21 | 3.41 | 3.16 |
Oct-25 | 3.28 | 3.25 | 3.53 | 3.17 |
Oct-28 | 3.08 | 3.20 | 3.23 | 3.06 |
Oct-29 | 3.16 | 2.79 | 3.35 | 2.52 |
Oct-30 | 2.71 | 1.93 | 2.85 | 1.90 |
Oct-31 | 0.93 | 0.62 | 0.98 | 0.54 |
Nov-1 | 0.61 | 0.58 | 0.61 | 0.55 |
Nov-4 | 0.56 | 0.57 | 0.58 | 0.51 |
Nov-5 | 0.56 | 0.55 | 0.57 | 0.52 |
Nov-6 | 0.54 | 0.53 | 0.56 | 0.50 |
Nov-7 | 0.52 | 0.56 | 0.57 | 0.50 |
Nov-8 | 0.61 | 0.70 | 0.76 | 0.60 |
Nov-11 | 0.69 | 0.90 | 1.08 | 0.69 |
Nov-12 | 0.84 | 0.75 | 0.97 | 0.69 |
Matinas BioPharma Holdings Earnings
Data Unavailable
Matinas BioPharma Holdings Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $1.35 per share.
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.